Leibniz-Forschungsinstitut für Molekulare Pharmakologie

Leibniz-Forschungsinstitut für Molekulare Pharmakologie

The Leibniz-Forschungsinstitut für Molekulare Pharmakologie is a research institute in the Leibniz Association, focussing on proteins as basic structures of cellular organisms. It is one of the large number of research institutions based in Berlin. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Germany, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

59%


Total
Publications

2.1K


Total Open
Publications

1.2K


Total
Citations

89K


Open Access
Percentage

59%


Total
Publications

2.1K


Total Open
Publications

1.2K


Total
Citations

89K

Wikipedia

Website

download

Breakdown

16% 31% 12% 41%

Publisher Open

16%

Both

31%

Other Platform Open

12%

Closed

41%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

49%OA Journal

OA Journal 49%

471

Hybrid 27%

261

No Guarantees 24%

225

Other Platform Open

Domain 60%

529

Institution 42%

373

Other Internet 21%

182

Preprint 14%

126

Public 4%

34

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
525
DOI
Other Internet
178
bioRxiv
Preprint
121
ZB MED - Information Centre for Life Sciences
Institution
116
Freie Universität Berlin
Institution
69
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
41
Europe PMC
Domain
39
Royal Netherlands Academy of Arts and Sciences
Institution
33
Humboldt-Universität zu Berlin
Institution
25
Max Planck Society
Institution
24
1 / 11

Data updated 18 August 2025

Share

Share

Share